Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Succinyl ononin and applications of succinyl ononin in preparation of cardiovascular disease medicine

A succinyl formonioides and cardiovascular technology, applied in the field of medicine, can solve the problems of high structural toxicity, high cost, complicated purification steps and the like, and achieve the effect of high water solubility

Active Publication Date: 2017-01-18
NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Xu Feng et al. used formononetin to prepare vasodilator drugs (CN 104107184 A). In their work, formononetin was obtained by separating plant components with high cost, cumbersome purification steps and high toxicity of the separated structure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Succinyl ononin and applications of succinyl ononin in preparation of cardiovascular disease medicine
  • Succinyl ononin and applications of succinyl ononin in preparation of cardiovascular disease medicine
  • Succinyl ononin and applications of succinyl ononin in preparation of cardiovascular disease medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Screening and identification of strains producing succinylformononetin in non-aqueous phase

[0034] Take about 1g of soil sample, add it to the Erlenmeyer flask containing 20mL of screening medium, 30℃, 180r·min -1 The cells were incubated with shaking in a water bath for 24 hours, and then transferred 3 times with 5% inoculum. After appropriate dilution of the culture liquid, it was diluted and spread with LB plate medium, cultured at 30°C for 24 hours, the colony morphology was observed, and then single colonies were picked and streaked on the LB plate medium to obtain single clones, and the strains obtained by screening were screened. numbered and cryopreserved at ultra-low temperature.

[0035] Using sucrose as the growth carbon source of organic solvent-resistant bacteria and adding 20% ​​(v / v) dimethylformyl as the screening pressure, organic solvent-resistant extremophiles were obtained by screening and separating from chemically polluted soil samples.

[0036...

Embodiment 2

[0041] Fermentation of Bacillus amyloliquefaciens FJ18 and Preparation of Resting Cells

[0042] The fermentation of Bacillus amyloliquefaciens FJ18 was inoculated into the seed medium: yeast extract 5.0 g / L, peptone 10.0 g / L, NaCl 10.0 g / L, pH 7.0, cultured at 30° C., 200 rpm for 12 hours. Expansion medium and fermentation medium, whose components and contents are: sucrose 20g / L, yeast powder 15g / L.KH 2 PO 4 1.0g / L, CaCl 2 0.8g / L. The pH was adjusted to 8.0 with NaOH. The seed liquid was inoculated into expansion medium and fermentation medium at 0.5% (v / v), and cultured at 30° C. and 200 rpm for 12 hours. After centrifugation at 10,000 rpm for 15 minutes, the bacterial cells were collected and washed with physiological saline for 1-2 times to obtain the resting cells of Bacillus amyloliquefaciens FJ18.

Embodiment 3

[0044] The bacterial cell fermentation broth in Example 2 was filtered to obtain wet bacterial cells. The raw material solution, namely the reaction solution, is prepared with dimethyl sulfoxide, formononetin, sucrose and phosphate buffer. The ratio of organic solvent dimethyl sulfoxide in the reaction solution is 20% (v / v), formononetin 0.5g / L, the molar concentration of phosphate buffer is 150mmol / L, the pH of phosphate buffer is 8.0, and the sucrose concentration is 50g / L. The wet cells obtained above were dispersed in the reaction solution, added to the reactor, cultured at 30°C and 200rpm for 24h, centrifuged at 10,000rpm for 10 minutes to obtain the supernatant of the reaction solution, and the HPLC detection and analysis detected the conversion of formononetin. The rate was 97.2%.

[0045] The product was separated with macroporous resin, and an appropriate amount of resin was taken and soaked in ethanol for 24 hours to remove resin fragments and debris. wet packing...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a medicine adopting succinyl ononin represented by a formula (1) and a pharmaceutically acceptable salt as an active component, and applications of the medicine in preparation of a cardiovascular disease medicine, particularly to applications of succinyl ononin and a pharmaceutically acceptable salt in preparation of an anti-myocardial ischemia drug, and belongs to the technical field of medicines. According to the present invention, the provided succinyl ononin is the new ononin derivative, has high water solubility and low toxicity, provides significant treatment effects for cardiovascular diseases, especially myocardial ischemic diseases, and provides the new drug selection for cardiovascular diseases. The formula (1) is defined in the specification.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to the application of a succinyl formononein and a pharmaceutically acceptable salt in the preparation of a drug for cardiovascular diseases, in particular to a succinyl formononein and a pharmaceutically acceptable salt Application in the preparation of anti-myocardial ischemia drugs. Background technique [0002] Flavonoids are plant secondary metabolites, which are widely found in natural plants, in the form of free state or combined with sugar as glycosides. Its pharmacological activity can prevent and treat cardiovascular and cerebrovascular diseases and respiratory diseases, and has pharmacological effects such as anti-inflammatory, antibacterial, hypoglycemic, anti-oxidative, anti-radiation, anti-cancer, anti-tumor and immune enhancement. In recent years, the research on flavonoids has entered a new level. With the in-depth study of their structure-activity relationship, the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H1/00C07H17/07A61K31/7048A61P9/10A61P9/04A61P9/06
CPCC07H1/00C07H17/07
Inventor 张森段金廒顾俊菲翁泽斌
Owner NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com